G MED INNOVATIONS HLDGS LTD
SHS NEW · CUSIP G39462125
2
institutional holders
-5 vs Q4 2022
1
shares reported held*
$1reported value*
1 new
0 added
0 reduced
6 sold out
net sold ≈ $66.6k (-66.6k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.00.
Trends to Q1 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2022 | 7 |
| Q1 2023 | 2 |
Biggest buyers
| BARCLAYS PLC | New | +1 |
Biggest sellers
| JPMORGAN CHASE & CO | Sold out | -60.2k |
| MACQUARIE GROUP LTD | Sold out | -2.9k |
| UBS Group AG | Sold out | -2.2k |
| BANK OF AMERICA CORP /DE/ | Sold out | -1.2k |
| HighMark Wealth Management LLC | Sold out | -47 |
| HARBOUR INVESTMENTS, INC. | Sold out | -20 |
Holders, Q1 2023
| Manager | Shares | Change |
|---|---|---|
| BARCLAYS PLC 0.00% of their portfolio | 1 $1 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |